Results 51 to 60 of about 113,590,771 (217)
Hyperargininemia in an inducible arginase‐1 deficient mouse model
We generated an inducible arginase‐1 (Arg1) deficient mouse model by crossing “floxed” Arg1 mice with the Cre‐ER‐T2 model (Arg1‐Cre). These Arg1‐Cre mice die about 2 weeks after tamoxifen administration regardless of the starting age of inducing the knockout and show signs of hyperammonemia and significantly elevated arginine levels (n=4–5; four time ...
Angie Sin +7 more
openaire +1 more source
Background Using guinea pig tracheal preparations, we have recently shown that endogenous arginase activity attenuates inhibitory nonadrenergic noncholinergic (iNANC) nerve-mediated airway smooth muscle relaxation by reducing nitric oxide (NO) production
Zaagsma Johan +4 more
doaj +1 more source
Background Hypertension‐induced cardiovascular remodeling is characterized by chronic low‐grade inflammation. Interleukin‐4 receptor α (IL‐4Rα) signaling is importantly involved in cardiovascular remodeling, however, the target cell type(s) is unclear ...
Jianrui Song +7 more
doaj +1 more source
Arginase 1 (Arg1) is a ubiquitous enzyme belonging to the urea cycle that catalyzes the conversion of l-arginine into l-ornithine and urea. In endothelial cells (ECs), Arg1 was proposed to limit the availability of l-arginine for the endothelial nitric oxide synthase (eNOS) and thereby reduce nitric oxide (NO) production, thus promoting endothelial ...
Sophia K. Heuser +19 more
openaire +3 more sources
An established pig lung transplantation model was used to study the effects of cold ischemia time, normothermic acellular ex vivo lung perfusion (EVLP) and reperfusion after lung transplantation on l-arginine/NO metabolism in lung tissue.
Farshad Tavasoli +7 more
doaj +1 more source
Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency
Arginase deficiency is caused by deficiency of arginase 1 (ARG1), a urea cycle enzyme that converts arginine to ornithine. Clinical features of arginase deficiency include elevated plasma arginine levels, spastic diplegia, intellectual disability ...
Lee, Brendan H +13 more
core +1 more source
This study shows crosstalk among tumor cells, fibroblasts, and macrophages alters the physical forces inside 3D tumor spheroids. Incorporating deformable microparticles in 3D tumor spheroids, the researchers mapped mechanical stresses spatially and with respect to tumor growth (temporally).
Kunal P. Pednekar +2 more
wiley +1 more source
Cytokine Signaling Protein 3 (SOCS3) deficiency in myeloid cells promotes retinal degeneration and angiogenesis through arginase-1 up-regulation in experimental autoimmune uveoretinitis [PDF]
The suppressor of cytokine signalling protein 3 (SOCS3) critically controls immune cell activation, although its role in macrophage polarization and function remains controversial.
Xu, Heping +17 more
core +1 more source
CCL22‐releasing PLGA microparticles (MP) suspended in topically applied hydrogels (HEART) establish a sustained chemokine gradient at the injured myocardium. HEART recruits CCR4+ regulatory T cells, reduces infarct size and graft fibrosis, and improves cardiac function.
Matthew A. Borrelli +8 more
wiley +1 more source
Arginase-2 mediates diabetic renal injury [PDF]
OBJECTIVE—To determine 1) whether renal arginase activity or expression is increased in diabetes and 2) whether arginase plays a role in development of diabetic nephropathy (DN). RESEARCH DESIGN AND METHODS—The impact of argi-nase activity and expression
Sidney M. Morris +4 more
core +1 more source

